ABP 501

Generic Name: ABP 501
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20110217Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriaticarthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis1A Randomized, Single-Blind, Single-Dose, 3-Arm, Parallel-Group Study to Determine the Pharmacokinetic Equivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Subjects
20120262Rheumatoid Arthritis3A Randomized, Double-blind, Phase 3 Study of ABP 501 Efficacy and Safety Compared to Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis
20120263Plaque Psoriasis3A Phase 3, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Plaque Psoriasis